Business
Eiko Lifesciences Limited Press Release Jan 29 2026
Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), and amendments thereto, this is to inform that the Meeting of the Board of Directors of the Company held today i.e. on Thursday, 29th January, 2026, Board, inter-alia, considered and approved Unaudited Financial Results (Standalone & Consolidated basis) for the Quarter ended 31st December, 2025. The Statutory Auditors have carried out a 'Limited Review' of the Unaudited Financial Results for the Quarter ended 31st December, 2025. Further, Pursuant to the Regulation 33 of the Listing Regulations, we are enclosing herewith a copy of the Unaudited Financial Results and Limited Review Report of the Statutory Auditors of the Company. The Meeting was commenced at 12: 30 PM and concluded at 13:00 PM.
About this update from Eiko Lifesciences Limited
Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), and amendments thereto, this is to inform that the Meeting of the Board of Directors of the Company held today i.e. on Thursday, 29th January, 2026, Board, inter-alia, considered and approved Unaudited Financial Results (Standalone & Consolidated basis) for the Quarter ended 31st December, 2025. The Statutory Auditors have carried out a 'Limited Review' of the Unaudited Financial Results for the Quarter ended 31st December, 2025. Further, Pursuant to the Regulation 33 of the Listing Regulations, we are enclosing herewith a copy of the Unaudited Financial Results and Limited Review Report of the Statutory Auditors of the Company. The Meeting was commenced at 12: 30 PM and concluded at 13:00 PM. View Attachment
View stock analysis, news, and events for Eiko Lifesciences Limited